EUROBIO-SCIENTIFIC (EPA:ALERS) | WebDisclosure

Basculer en Français

10965	Companies
240137	Keywords
168910	Articles
129233	Press releases

Home
Companies
EUROBIO-SCIENTIFIC

PRESS RELEASE

published on 10/23/2024 at 08:30, 1 year 10 months ago

Eurobio Scientific: Communiqué de mise à disposition du public des informations relatives aux caractéristiques notamment juridiques, financières et comptables de la société Eurobio Scientific SA
Communiqué de mise à disposition du public des informations relatives à l'Offre Publique d'Achat visant les actions de la société Eurobio Scientific SA par la société EB Development et ses partenaires

Offre Publique D'achat AMF Communiqué EB Development Eurobio Scientific SA
PRESS RELEASE

published on 10/23/2024 at 08:30, 1 year 10 months ago

COMMUNIQUÉ RELATIF À LA MISE À DISPOSITION DES INFORMATIONS RELATIVES AUX CARACTÉRISTIQUES, NOTAMMENT JURIDIQUES, FINANCIÈRES ET COMPTABLES D’EB DEVELOPMENT DANS LE CADRE DE L’OFFRE PUBLIQUE D’ACHAT VISANT LES ACTIONS D'EUROBIO SCIENTIFIC
Communiqué du 23 octobre 2024 relatif à l'offre publique d'achat d'actions d'Eurobio Scientific par EB Development. Prix, durée, et procédure de retrait obligatoire détaillés

Offre Publique D'achat AMF Eurobio Scientific EB Development Procédure De Retrait
PRESS RELEASE

published on 09/24/2024 at 19:05, 1 year 11 months ago

Eurobio Scientific: Rapport financier semestriel 2024
BRIEF

published on 08/02/2024 at 07:35, 2 years 1 month ago

Eurobio Scientific finalise l'acquisition du test génomique EndoPredict® de Myriad Genetics

Acquisition Tests Génomiques Eurobio Scientifique EndoPredict Une Myriade De Génétique
BRIEF

published on 08/02/2024 at 07:35, 2 years 1 month ago

Eurobio Scientific Completes Acquisition of EndoPredict® Genomic Test from Myriad Genetics

Acquisition Eurobio Scientific EndoPredict Myriad Genetics Genomic Tests
PRESS RELEASE

published on 08/02/2024 at 07:30, 2 years 1 month ago

EUROBIO SCIENTIFIC COMPLETES ACQUISITION OF ENDOPREDICT® GENOMIC TEST FROM MYRIAD GENETICS
Eurobio Scientific finalizes acquisition of EndoPredict genomic test from Myriad Genetics, expanding its diagnostic test portfolio and distribution network

Acquisition Eurobio Scientific EndoPredict Myriad Genetics Genomic Test
PRESS RELEASE

published on 08/02/2024 at 07:30, 2 years 1 month ago

EUROBIO SCIENTIFIC FINALISE L’ACQUISITION DU TEST GÉNOMIQUE ENDOPREDICT® AUPRÈS DE MYRIAD GENETICS
Eurobio Scientific finalise l’acquisition du test génomique EndoPredict® auprès de Myriad Genetics, renforçant son leadership dans le diagnostic médical in vitro. Pour plus d'informations, visitez www.eurobio-scientific.com

Diagnostic Médical Eurobio Scientific Myriad Genetics Test Génomique EndoPredict®
BRIEF

published on 07/31/2024 at 21:08, 2 years 1 month ago

EUROBIO SCIENTIFIC : Accord d'offre publique d'achat volontaire

Offre Publique D'achat Diagnostic In Vitro Eurobio Scientifique Partenaires CI Étape Suivante AM
BRIEF

published on 07/31/2024 at 21:08, 2 years 1 month ago

EUROBIO SCIENTIFIC: Agreement for a Voluntary Tender Offer

In Vitro Diagnostics Tender Offer Eurobio Scientific IK Partners NextStage AM
BRIEF

published on 07/31/2024 at 21:06, 2 years 1 month ago

Eurobio Scientific : Un premier semestre 2024 robuste dans un contexte d'incertitude

Offre Publique D'achat Acquisitions Hausse Des Revenus Eurobio Scientifique Produits Exclusifs

Accesswire

Published on 09/12/2026 at 02:35, 11 hours 32 minutes ago

Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 15 hours 7 minutes ago

Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 16 hours 2 minutes ago

Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 42 minutes ago

Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 21 hours 7 minutes ago

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors

View all ACCESSWIRE

EQS Group

Published on 09/12/2026 at 07:30, 6 hours 36 minutes ago

NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 52 minutes ago

Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 56 minutes ago

Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 18 hours 22 minutes ago

DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 51 minutes ago

CGTN: How BRICS creates new opportunities for Global South development

Les Echos

Published on 09/11/2026 at 07:00, 1 day 7 hours ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 1 day 7 hours ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 1 day 7 hours ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 7 hours ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE